• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream

    9/23/25 7:00:00 AM ET
    $ADVM
    $AIIO
    $BANL
    $BNZI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Auto Manufacturing
    Industrials
    Get the next $ADVM alert in real time by email

    MIAMI, Sept. 23, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1 - Wednesday

    September 24, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Eshallgo, Inc. (NASDAQ:EHGO)

    Keynote speakers: Johnny Wu, President

    9:40 – 10:10

    Kneat.com, Inc., (OTCQX:KSIOF) (TSX:KSI)

    Keynote speaker: Edmund Ryan, CEO

    10:15 – 10:45

    Robo.ai Inc. (NASDAQ:AIIO)

    Keynote speaker: Benjamin Bin Zhai - CEO & Executive Director

    10:50 – 11:20

    Zapp Electric Vehicles Group, Ltd. (OTCQB:ZAPPF)

    Keynote speaker: David McIntyre, CEO

    11:25 – 11:55

    BluSky AI Inc. (OTCID: BSAI)

    Keynote speaker: Trent D'Ambrosio, Founder, CEO, and Dan Gray, COO

    12:00 – 12:30

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    12:35 – 1:05

    Stallion Uranium Corp. (OTCQB:STNLF) (TSXV:STUD) 

    Keynote speaker: Darren Slugoski, VP Exploration

    1:10 – 1:40

    CBL International Limited (NASDAQ:BANL)

    Keynote speaker: Dr. Teck Lim CHIA, William, Chairman and Chief Executive, and Ms. Venus Zhao, IR & PR Director

    1:45 – 2:15

    Citizens, Inc. (NYSE:CIA)

    Keynote speakers: Jon Stenberg, President / CEO, and Jeff Conklin, CFO

    2:55 – 3:05

    Vizsla Royalties Corp. (TSXV:VROY) (OTCQB:VROYF)

    Keynote speaker: Michael N. Pettingell, President and CEO

    3:10 – 3:20

    Adverum Biotechnologies (NASDAQ:ADVM)

    Keynote speaker: Jason Awe, PhD, MBA, Corporate Communications & IR

    3:40 – 3:50

    Banzai International, Inc. (NASDAQ:BNZI)

    Keynote speaker: Joseph Davy, Co-Founder, Chairman & CEO

    3:55 – 4:05

    Aurora Mobile Limited (NASDAQ:JG)

    Keynote speaker: Shan-Nen Bong, CFO

    4:10 – 4:20

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speakers: Chris Holden, VP Corporate Development

    4:25 – 4:35

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    _______________________________________________________________

    Day 2 – Thursday

    September 25, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    SBC Medical Group Holdings, Inc. (NASDAQ:SBC)

    Keynote speaker: Yuya Yoshida, Executive Vice President & CFO

    10:15 – 10:45

    Autris (OTCID: AUTR)

    Keynote speakers: Don Morrison, CFO, & Dan Patrick, CEO

    10:50 – 11:20

    First Phosphate Corp. (CSE:PHOS) (OTCQB:FRSPF)

    Keynote speaker: John Passalacqua, CEO

    11:25 – 11:55

    Tivic Health Systems, Inc.'s (NASDAQ:TIVC)

    Keynote speaker: Jennifer Ernst, Co-Founder, CEO

    12:00 – 12:30

    Questcorp Mining, Inc. (OTCQB:QQCMF) (CSE:QQQ)

    Keynote speaker: Saf Dhillon - CEO, President & Director

    12:35 – 1:05

    iMetal Resources, Inc. (OTCQB:IMRFF) (TSXV:IMR)

    Keynote speaker: Saf Dhillon - CEO, President & Director

    1:10 – 1:40

    StrikePoint Gold, Inc.'s (OTCQB:STKXF) (TSXV:SKP)

    Keynote speaker: Michael Gregory Allen, CEO, President & Director

    1:45 – 2:15

    Vivani Medical, (NASDAQ:VANI)

    Keynote speaker: Adam Mendelsohn PHD, CEO

    2:20 – 2:50

    Lifeloc Technologies, Inc. (OTCID: LCTC)

    Keynote speaker: Wayne Willkomm, President / CEO

    2:55 – 3:05

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    3:10 - 3:20

    Odyssey Marine Exploration, Inc. (NASDAQ:OMEX)

    Keynote speaker: Mark D. Gordon, Chairman & CEO

    3:25 – 3:35

    Medicenna Therapeutics Corp. (OTCQX:MDNAF) (TSX:MDNA)

    Keynote speaker: Fahar Merchant, President and CEO

    3:40 – 3:50

    Surf Air Mobility, Inc. (NYSE:SRFM)

    Keynote speakers: Deanna White, CEO and Oliver Reeves, CFO

    3:55 – 4:05

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speakers: David Dodd, Chairman, President / CEO

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $AIIO
    $BANL
    $BNZI

    CompanyDatePrice TargetRatingAnalyst
    Adverum Biotechnologies Inc.
    $ADVM
    11/17/2025Buy → Neutral
    H.C. Wainwright
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    Surf Air Mobility Inc.
    $SRFM
    4/2/2025$3.25Hold → Buy
    Canaccord Genuity
    GeoVax Labs Inc.
    $GOVX
    11/11/2024$15.00Buy
    Alliance Global Partners
    GeoVax Labs Inc.
    $GOVX
    7/16/2024$20.00Buy
    ROTH MKM
    Adverum Biotechnologies Inc.
    $ADVM
    6/25/2024$25.00Outperform
    Oppenheimer
    Surf Air Mobility Inc.
    $SRFM
    5/15/2024$2.50 → $1.00Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, PRESIDENT AND DIRECTOR Fischer Laurent exercised 150,000 shares at a strike of $4.20 and was granted 500,000 units of Common Stock - Performance Stock Units, closing all direct ownership in the company (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/10/25 1:52:31 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CHIEF OPERATING OFFICER Soparkar Peter was granted 150,000 units of Common Stock - Performance Stock Units, closing all direct ownership in the company (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/10/25 1:49:41 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Medical Officer Ozden Rabia Gurses was granted 85,000 units of Common Stock - Performance Stock Units, closing all direct ownership in the company (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/10/25 1:46:33 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $AIIO
    $BANL
    $BNZI
    SEC Filings

    View All

    SEC Form 424B3 filed by Robo.ai Inc.

    424B3 - ROBO.AI INC. (0001932737) (Filer)

    12/15/25 4:05:30 PM ET
    $AIIO
    Auto Manufacturing
    Industrials

    SEC Form DEF 14A filed by Banzai International Inc.

    DEF 14A - Banzai International, Inc. (0001826011) (Filer)

    12/15/25 4:00:38 PM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Robo.ai Inc.

    6-K - ROBO.AI INC. (0001932737) (Filer)

    12/15/25 7:31:11 AM ET
    $AIIO
    Auto Manufacturing
    Industrials

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Adverum Biotech downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Adverum Biotech from Buy to Neutral

    11/17/25 9:39:07 AM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    D. Boral Capital reiterated coverage on GeoVax Labs with a new price target

    D. Boral Capital reiterated coverage of GeoVax Labs with a rating of Buy and set a new price target of $14.00 from $18.00 previously

    4/15/25 7:54:48 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Alliance Global Partners reiterated coverage on GeoVax Labs with a new price target

    Alliance Global Partners reiterated coverage of GeoVax Labs with a rating of Buy and set a new price target of $8.50 from $15.00 previously

    4/15/25 7:54:17 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Odyssey Marine Exploration's Unsolicited Request for a U.S. Offshore Mineral Lease Sale Advances as BOEM Initiates Formal Review Process

    A year of policy alignment, project advancement, and balance-sheet strengthening sets the stage for continued progress in 2026 Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a U.S.-based ocean exploration and marine resource development leader, received news that the Bureau of Ocean Energy Management's (BOEM), a department of the U.S. Department of Interior (DOI) has initiated the formal review process for its unsolicited request for a potential marine mineral lease sale in federal waters offshore Virginia. "BOEM's decision to initiate this process is an important step toward responsibly evaluating the mineral potential of the U.S. Outer Continental Shelf," said Mark Gordon, Chairman and

    12/15/25 8:30:00 AM ET
    $GLDD
    $OMEX
    Military/Government/Technical
    Industrials
    Marine Transportation
    Consumer Discretionary

    SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares

    Strategic acquisition strengthens SBC's comprehensive service offerings and R&D capabilities SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services for medical organizations, today announced the final results of its tender offer for common shares of Waqoo, Inc. (TYO:4937) (the "Tender Offer"), a medical research and development company specializing in regenerative medicine technologies, listed on the Tokyo Stock Exchange Growth Market. The tender offer, which commenced on November 14, 2025 and concluded on December 12, 2025, was conducted at JPY 1,900 per share. Through the Tender Offer,

    12/12/25 11:00:00 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Robo.ai Inc. Reaches a $180 Million Financing Agreement with ATW Partners

    DUBAI, UAE, Dec. 12, 2025 /PRNewswire/ -- Robo.ai Inc. (NASDAQ:AIIO), a technology platform dedicated to "AI, Smart Device and Smart Asset", today announced that it has entered into definitive agreements with ATW Partners (www.atwpartners.com) for a total of $180 million financing arrangement. The financing is comprised of $80 million in convertible notes and a $100 million equity purchase facility commitment. The Company also announced that it has completed the first tranche of the transaction on December 11, 2025. The Company intends to utilize the proceeds from this financi

    12/12/25 8:03:00 AM ET
    $AIIO
    Auto Manufacturing
    Industrials

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, PRESIDENT AND DIRECTOR Fischer Laurent bought $553,917 worth of shares (128,699 units at $4.30), increasing direct ownership by 177% to 201,513 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:06 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CHIEF OPERATING OFFICER Soparkar Peter bought $211,000 worth of shares (50,000 units at $4.22), increasing direct ownership by 166% to 80,189 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:04 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Williams Gregg bought $1,983,333 worth of shares (1,737,764 units at $1.14) (SEC Form 4)

    4 - Vivani Medical, Inc. (0001266806) (Issuer)

    11/17/25 9:00:21 AM ET
    $VANI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Leadership Updates

    Live Leadership Updates

    View All

    CBL Appoints Mr. Yuan He to Board of Directors

    KUALA LUMPUR, Nov. 19, 2025 (GLOBE NEWSWIRE) -- CBL International Limited (NASDAQ:BANL) (the "Company" or "CBL"), the listing vehicle of the Banle Group ("Banle" or "the Group"), a leading marine fuel logistics company in the Asia-Pacific region, is pleased to announce the appointment of Mr. Yuan He to its board of directors, effective December 1, 2025. Mr. Yuan He has been serving as senior vice president of the Company and its predecessor entity since the inception of the Group in 2015. He is primarily responsible for the bunkering business division and the Group's management and strategic development. With over 17 years of experience in the oil and gas-related industries and business m

    11/19/25 7:30:00 AM ET
    $BANL
    Oil Refining/Marketing
    Energy

    Lilly to Acquire Adverum Biotechnologies

    Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose  Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases  INDIANAPOLIS and REDWOOD CITY, Calif., Oct. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adve

    10/24/25 8:30:00 AM ET
    $ADVM
    $LLY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

    Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual Constellation Forum, a global conversation on Bioelectronic Medicine. She will join other leaders in the field to discuss the opportunities for advancing bioelectronic medicine. When: Thursday, Oct. 23, at 11:55 a.m. ET/8:55 a.m. PT Panel Title: Building a Big Tent Bioelectronic Medicine stands to disrupt how we diagnose, treat, and manage disease, but fulfilling that promise requires broad alignment across the healthcare ecosystem. This session will explore how to rally the global community,

    10/22/25 2:00:00 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Financials

    Live finance-specific insights

    View All

    Banzai Reports Third Quarter 2025 Financial Results

    Revenue of $2.8 Million for Q3 2025, up 163% from Q3 2024 Gross Profit of $2.3 Million for Q3 2025, a 213% increase from Q3 2024; Gross Margin Expanded to 81.7% in Q3 2025, a 1,302 BPS Increase Management to Host Third Quarter 2025 Results Conference Call Today, Friday, November 14, 2025 at 4:30 p.m. Eastern Time SEATTLE, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ:BNZI) ("Banzai" or the "Company"), a leading marketing technology company that provides essential marketing and sales solutions, today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 and Subsequent Key Financial & Operational Highlights

    11/14/25 4:10:00 PM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced its financial results for the third quarter of fiscal year 2025 (three months ended September 30, 2025) and for the third quarter cumulative of fiscal year 2025 (Year-to-Date 2025, nine months ended September 30, 2025) Third Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $16 million, representing a 15% year-over-year increase. Net Income attributable to SBC Medical Group was $13 mill

    11/14/25 7:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Aurora Mobile Limited Announces Third Quarter 2025 Unaudited Financial Results

    SHENZHEN, China, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited ("Aurora Mobile" or the "Company") (NASDAQ:JG), a leading provider of customer engagement and marketing technology services in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Revenues were RMB90.9 million (US$12.8 million), an increase of 15% year-over-year.Cost of revenues was RMB27.1 million (US$3.8 million), an increase of 5% year-over-year.Gross profit was RMB63.8 million (US$9.0 million), an increase of 20% year-over-year.Total operating expenses were RMB64.4 million (US$9.0 million), an increase of 13% year-over-year

    11/13/25 5:30:00 AM ET
    $JG
    Computer Software: Programming Data Processing
    Technology

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:57:12 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:40:56 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by GeoVax Labs Inc.

    SC 13G/A - GeoVax Labs, Inc. (0000832489) (Subject)

    11/14/24 5:10:48 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care